NeuropeptideYgene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsyNOE, Francesco; POOL, Allan-Hermann; PITKINEN, Asia et al.Brain. 2008, Vol 131, pp 1506-1515, issn 0006-8950, 10 p., 6Article

Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesityLIN, En-Ju D; SAINSBURY, Amanda; LEE, Nicola J et al.Endocrinology (Philadelphia). 2006, Vol 147, Num 11, pp 5094-5101, issn 0013-7227, 8 p.Article

Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate rewardOLSON, Valerie G; HEUSNER, Carrie L; BLAND, Ross J et al.Science (Washington, D.C.). 2006, Vol 311, Num 5763, pp 1017-1020, issn 0036-8075, 4 p.Article

Regulation of the postnatal development of dopamine neurons of the substantia nigra in vivo by Akt/protein kinase BRIES, Vincent; CHENG, Hsiao-Chun; BAOHAN, Amy et al.Journal of neurochemistry. 2009, Vol 110, Num 1, pp 23-33, issn 0022-3042, 11 p.Article

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease : an open label, phase I trial. CommentarySTOESSL, A. Jon; KAPLITT, Michael G; EIDELBERG, David et al.Lancet (British edition). 2007, Vol 369, Num 9579, issn 0140-6736, 2056-2058, 2097-2105 [12 p.]Article